Home > Insider Trading > Filing (0000899243-20-019542)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1537917	Tyme Technologies Inc.	TYME	Pharmaceutical Preparations (2834)	453864597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711342	Steve Hoffman	C/O Tyme Technologies, Inc. 17 State Street - 7Th Floor New York NY 10004	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-07-15	25,799	$1.27	26,466,949	No	4	S	Direct
Common Stock	Disposition	2020-07-16	25,500	$1.25	26,441,449	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.24 to $1.29, inclusive on July 15, 2020 and prices ranging from $1.23 to $1.32, inclusive, on July 16, 2020. The reporting person undertakes to provide to Tyme Technologies, Inc., any security holder of Tyme Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.